Mersana Therapeutics Is A Clinical Stage Biopharmaceutical Company Based In Cambridgemassachusettsthe Company Is Focused On Developing Innovative Antibody Drug Conjugatesadcsaimed At Treating Cancermersana S Mission Is To Create Life Changing Therapies For Patients Battling Cancerwith A Vision Of A World Where All Patients Can Overcome The Disease The Company Utilizes Its Proprietary Adc Platformsdolasynthen And Immunosynthento Develop Targeted Cancer Treatmentsdolasynthen Delivers Cytotoxic Payloads To Directly Kill Cancer Cellswhile Immunosynthen Delivers Immunostimulatory Payloads To Enhance The Immune Response Against Tumorsmersana S Pipeline Includes Several Adc Candidatessuch As Emi Lexmt 1660 Xmt 2056Xmt 2068And Xmt 2175Which Are Designed For Various Solid Tumors Mersana Actively Participates In Healthcare Conferences To Present Its Advancements In The Biopharmaceutical Field And Is Listed On Nasdaq Under The Ticker Symbol Mrsn
